Paddy Gillespie

Paddy Gillespie


Paddy Gillespie is Established Professor of Health Economics at the J.E. Cairnes School of Business & Economics and the Director of the Health Economics & Policy Analysis Centre (HEPAC) at NUI Galway. His research activity is focused on the application of the techniques of health economic evaluation and health econometrics to inform health policy and practice.

Prof Gillespie’s work has involved the application of health economics techniques to explore a variety of questions in relation to heart disease, diabetes, dementia, chronic obstructive pulmonary disorder, stroke, obesity, multimorbidity, infectious disease and personalised medicine. The output from this work, which has involved collaboration with colleagues across multiple disciplines, has been published in a range of leading national and international peer-reviewed journals.

Prof Gillespie predominant methodological area of expertise is health economic evaluation, which incorporates a set of techniques that explore the cost, budget impact and cost effectiveness of healthcare technologies and interventions. The evidence generated from such studies goes to inform reimbursement decisions in public and private health sectors.

Prof Gillespie is a health economics educator for the Health Research Board Trials Methodology Research Network (HRB-TMRN), and the health economics lead for the Health Research Board Primary Care Clinical Trials Network Ireland (HRB Primary Care CTNI) and the Centre for Personalised Medicine (CPM).

Prof Gillespie has published more than 40 peer-reviewed publications and has had success as a co-applicant, co-investigator, and collaborator on grant funding applications to agencies such as the Health Research Board (HRB), Science Foundation Ireland (SFI), and the European INTERREG fund.

Prof Gillespie is a research affiliate at the Economic and Social Research Institute (ESRI). He also serves as a member of the Health Technology Assessment Expert Group (HTAEG) which advises the Health Service Executive on the reimbursement of medical devices in Ireland.

Related Links